Clinical trial
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
NCT03357874 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 28, 2018
- Completion date
- July 18, 2023
- Enrollment
- 259 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.